FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

DOJ Releases Massive Trove of Epstein Files Documents, Statement on Trump Involvement

Rep Jeffries escalates rhetoric against Noem, says DHS leader should be ‘put on ice permanently’

‘Opening Pandora’s Box’: Mike Johnson backs Trump after warning White House about deal with Democrats

Pam Bondi Releases Video Statement After the Arrest of Don Lemon: ‘We Are Coming After You’

Panama court cancels Hong Kong canal contracts, handing Trump win

Federal judge strikes down parts of Trump executive order on citizenship verification for voter registration

With Trump weighing military operations against Iran, questions remain on targets and objectives

Hillary Clinton’s Hit Piece Against Several Christian Leaders Doesn’t Get the Response She Was Hoping for: ‘I’ve Never Been More Proud’

Looming government shutdown threatens service members, FEMA, TSA amid ICE impasse

Don Lemon Charged with Civil Rights Crimes for St. Paul Church Storming

Fox News Campus Radicals Newsletter: Dems target military college, anti-ICE nurse fury, more union follies

California woman arrested after allegedly beheading boyfriend, fleeing to Mexico

Pastor of Cities Church Speaks Out After Don Lemon’s Arrest

Behind the scenes: Trump and White House rally behind Noem as ‘radicals’ demand ouster

US escalates sanctions on Iranian officials as Trump considers military options

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”